R&D Francis del Val, President & Managing Director of GSK, Philippines, talks about his experience working in the pharmaceutical and healthcare sector in the Philippines, and discusses at length the company’s (and industry’s) largest challenge: Employee retention. The growth of the pharmaceutical market, according to IMS Health data, is only set…
R&D John Soloninka, President & CEO of HTX, talks about his vast experience in the pharmaceutical and healthcare sector, why he feels there is much room for growth in Canada still, and his strategy for the company’s international exposure. How did you come to lead HTX and what are the parallels…
R&D Pierre Montanaro, President and CEO of Pharmetics, discusses the history of his company’s work in the private label business and future plans to expand into a wider variety of areas within the industry. What opportunity did you see in moving your career from Pharmascience to Pharmetics? The business opportunity was…
R&D Wendy Adams, General Manager of Galderma Canada, speaks about the importance of the Canadian market for the global company, what sets Galderma apart from its competitors, and where she sees the company’s continued expansion rising to in the next three-five years. With over 20 years of history in Canada, what…
R&D The Chairman & CEO of SV More speaks about the path that led him to found the company nearly three decades ago, what changes need to be made in the future in order to maintain the current success of the company, and what aspect of his company makes him the…
See our Cookie Privacy Policy Here
